1. Home

Diclofenac's return to POM is 'step too far'

 
• By Annabelle Collins

Reclassification of NSAID is "slippery slope" towards loss of more P medicines, warn C+D readers

Diclofenac-50mg.jpg
The MHRA recalled OTC diclofenac from pharmacies last week because of a risk of "serious cardiac side effects"

Latest from News

More from Regulation